Physician profile
David Crabtree
NPI 1881080638
$530.63
in general payments reported to CMS, 2019-2025
9 companies · $182 in 2025
The $182 reported for 2025 was more than what a typical Addiction Medicine (Preventive Medicine) provider received nationally (typical 2025 total: $115).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $131 · 2023: $90.63 · 2024: $127 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $399.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $205.11 | 2023-2025 | Nucala |
| Inspire Medical Systems, INC. | $161.01 | 2022-2023 | Inspire |
| Hologic Sales and Service, LLC | $30.59 | 2024 | Aptima |
| Indivior INC. | $30.09 | 2024 | Sublocade |
| Pfizer INC. | $28.82 | 2024 | |
| Antares Pharma, INC. | $22.98 | 2024 | Xyosted |
| Takeda Pharmaceuticals U.S.A., INC. | $22.59 | 2025 | Glassia |
| Novo Nordisk INC | $14.86 | 2024 | |
| Optinose US, INC. | $14.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Crabtree listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.